JeffreyAKernMD

Critical Care Medicine, Pleural Disease, Thoracic Oncology

Professor of Medicine National Jewish Health / Professor of Medicine University of Colorado

Dr. Kern is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1400 Jackson St
Denver, CO 80206
Phone+1 303-388-4461

Fax+1 303-270-2206

Dr. Jeffrey Kern is a pulmonologist in Denver, CO and is affiliated with National Jewish Health. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 38 years. He specializes in critical care medicine, and thoracic oncology and is experienced in lung cancer, pulmonology, critical care medicine, and acute lung injury. He has more than 100 publications and over 6,000 citings.

General internal medicine, Pulmonology, Critical care medicine, Lung cancer, Thoracic oncology, Kinase signaling, Acute lung injury, ErbB-1 Genes

University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1984
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1979 - 1982
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1979 - 1980
University of Wisconsin School of Medicine & Public HealthClass of 1979

PubMed

Phenotype/Immunologic Profiling in ircAEs-Response.
Elena Goleva, Mario E Lacouture, Andrea P Moy, Jeffrey A Kern, Donald Y M Leung
Clinical Cancer Research. 2024-12-16
2 citations
Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Juan P Wisnivesky, Jeremy Mudd, Kimberly Stone, Christopher G Slatore, Raja Flores
Cancer. 2024-07-15
1 citations
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Mario E Lacouture, Elena Goleva, Neil Shah, Veronica Rotemberg, Lukas Kraehenbuehl
Clinical Cancer Research. 2024-07-01

Comparative Effectiveness of Limited Resection cs. Stereotactic Body Radiation Therapy for Early Stage Lung CancerNational Cancer Institute2016–2021
Kinase Dependent Chemotherapy Resistance Mechanisms in Small Cell Lung CancerNational Cancer Institute2016–2018
Heregulin Signaling in the Injured LungVA2005–2009
Nrg/Her Restoration Of The Lung Epithelium After InjuryNational Heart, Lung, And Blood Institute2005–2008
HER Receptor Family, Heregulin And Lung DevelopmentNational Heart, Lung, And Blood Institute2001–2002
HER Receptor Family, Heregulin And Lung DevelopmentNational Heart, Lung, And Blood Institute1999–2000
Physician Scientist AwardNational Heart, Lung, And Blood Institute1988–1990
Physician Scientist AwardNational Heart, Lung, And Blood Institute1986–1987